ETF Explainer: IHI

ETF Explainer: IHI

The U.S. medical devices space was a bit of a roller coaster.

Reviewed by: Heather Bell
Edited by: Heather Bell
iShares U.S. Medical Devices ETF

Each month, we look at an ETF selected by based on its performance and importance to investors. This month, we consider the performance of the $3.3 billion iShares U.S. Medical Devices ETF (IHI), which tracks the stocks of U.S. distributors and manufacturers of medical devices. All the companies mentioned below are holdings in IHI, unless otherwise noted (*).



For a larger view, please click on the image above.


MAR 23 Technology stocks plunge amid trade war tensions, with medical robotics company Intuitive Surgical hit harder than many of the other companies held by IHI

JUL 25 Thermo Fisher beat its revenue growth expectations for the second quarter by 22%. The company raised its 2018 forecast as a result.

AUG 21 Shares of Medtronic surge nearly 5% to a record high after exceeding analyst expectations for its fiscal first quarter, largely driven by sales in its diabetes and heart devices

SEP 24 Abbott Laboratories shares get a strong boost after a test involving its MitraClip implant to treat secondary mitral regurgitation, a complication of heart failure, sees good results.

DEC 24 Becton Dickinson shares are weighed down by divestitures and high raw material costs, but tick up near the end of the month after the FDA approves one of its diagnostic tests.

FEB 25 General Electric* agrees to sell its biopharmaceutical unit to Danaher to the tune of $21.4 billion, with the deal expected to close by the end of the year.

Source: Bloomberg. Data for 02/28/2018 to 02/28/2019

Heather Bell is a former managing editor of She has also held editorial positions at Dow Jones Indexes and Lehman Brothers. Bell is a graduate of Dartmouth college and resides in the Denver area with her two dogs.